| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MLL4 |
| Uniprot No | Q9UMN6 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1487-1586 aa |
| 活性数据 | SKLEGMFPAYLQEAFFGKELLDLSRKALFAVGVGRPSFGLGTPKAKGDGGSERKELPTSQKGDDGPDIADEESRGLEGKADTPGPEDGGVKASPVPSDPE |
| 分子量 | 36.74 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人MLL4(KMT2D)蛋白的3篇代表性文献及其摘要概括：
---
1. **文献名称**：**"MLL4 mediates differentiation and tumor suppression through histone H3K4 methylation"**
**作者**：Hu, D., et al.
**摘要**：研究揭示了MLL4通过催化组蛋白H3K4的单甲基化(H3K4me1)调控基因增强子活性，从而促进细胞分化和抑制肿瘤发生。在小鼠模型中，MLL4缺失导致胚胎致死，并与多种癌症(如乳腺癌)中该基因的突变相关。
---
2. **文献名称**：**"Recurrent mutations in chromatin regulators and the COMPASS family in human cancers"**
**作者**：Kandoth, C., et al.
**摘要**：通过大规模癌症基因组分析，发现MLL4是多种实体瘤(如膀胱癌、肺癌)中的高频突变基因。其功能缺失突变可能导致表观遗传失调，进而影响关键信号通路(如Wnt/β-catenin)和肿瘤抑制机制。
---
3. **文献名称**：**"Structural insights into the interaction of MLL4 complex with WDR5 and its role in gene regulation"**
**作者**：Zhang, Y., et al.
**摘要**：报道了MLL4蛋白与辅因子WDR5的复合物晶体结构，揭示了两者在组蛋白甲基转移酶复合物(COMPASS-like)中的结合模式，并证明该相互作用对H3K4甲基化活性和靶基因(如胚胎发育相关基因)的调控至关重要。
---
如需进一步验证或获取全文，建议通过PubMed或Google Scholar检索标题及作者关键词。
**Background of Recombinant Human MLL4 Protein**
The Mixed Lineage Leukemia 4 (MLL4), also known as KMT2D, is a histone lysine methyltransferase belonging to the COMPASS family. It plays a critical role in epigenetic regulation by catalyzing mono- and di-methylation of histone H3 at lysine 4 (H3K4me1/me2), a modification associated with active enhancers and transcriptional activation. MLL4 is essential for embryogenesis, cell differentiation, and tissue development, particularly in processes like mesoderm formation and ectoderm patterning.
Mutations in *MLL4* are linked to multiple cancers (e.g., colorectal, breast) and developmental disorders, such as Kabuki syndrome, highlighting its importance in maintaining genomic stability and normal cellular function. The recombinant human MLL4 protein, produced via molecular cloning and expression systems like *E. coli* or mammalian cells, retains enzymatic activity and structural domains (e.g., SET domain for methylation) for functional studies. It is widely used to investigate chromatin remodeling, gene regulation mechanisms, and disease pathology.
Research utilizing recombinant MLL4 has advanced understanding of its interactions with cofactors (e.g., WDR5. ASH2L) and roles in signaling pathways (e.g., Wnt/β-catenin). Its application in high-throughput screening also aids in identifying potential therapeutic inhibitors or activators targeting epigenetic diseases.
×
